Top Markets
#1 ADO Protocol ADO Protocol +233.73%
#2 Islamic Coin Islamic Coin +155.42%
#3 GoPlus Security GoPlus Security +60.87%
#4 Verus Coin Verus Coin +33.01%
#5 Starpower Starpower +28.54%
#6 GAIB AID GAIB AID +24.67%
#7 Casper Network Casper Network +16.10%
#8 o1.exchange o1.exchange +13.60%
#9 Status Status +11.71%
#10 Lumia Lumia +11.38%
Coin of the day
ADO Protocol ADO Protocol
設定
言語
日本
通貨
USD
テーマ
CNS Pharmaceuticals, Inc. CNS Pharmaceuticals, Inc.

CNS Pharmaceuticals, Inc.

CNSP
株式のランク #33273
CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical firm primarily... CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical firm primarily focused on developing innovative anti-cancer therapies for tumors affecting the brain and central nervous system. Its primary investigational compound, Berubicin, an anthracycline, is currently progressing through Phase I and II clinical trials as a potential treatment for glioblastoma multiforme, an aggressive form of brain cancer. To bolster its research and development initiatives, the company has entered into several strategic agreements. These include licensing arrangements with Houston Pharmaceuticals, Inc., The University of Texas M.D. Anderson Cancer Center, and Animal Life Sciences, LLC. Additionally, CNS Pharmaceuticals has a development agreement in place with WPD Pharmaceuticals Inc. and a collaborative partnership with Reata Pharmaceuticals, Inc. The company was founded in 2017 and is headquartered in Houston, Texas.
株価
$5.47
最終同期: 2026-08-14
時価総額
$7.99M
変化（1日）
6.21%
変化（1年）
7.47%
国
US
取引 CNS Pharmaceuticals, Inc. (CNSP)

カテゴリー

Healthcare
CNS Pharmaceuticals, Inc.（CNSP）のP/B比率
2026 時点のP/B比率 TTM: 0
CNS Pharmaceuticals, Inc. の最新の財務報告および株価によると、現在のP/B比率（TTM）は 0 です。2026 年末時点でのP/B比率は 0 でした。
CNS Pharmaceuticals, Inc. の P/B 比率の履歴（2026 ～ 2026）
各年末時点のP/B比率
年 P/B比率 変化
提供された日付のデータは十分ではありません。
同業他社のP/B比率
企業 P/B比率 P/B比率の差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.4612 -
BE